Price T Rowe Associates Inc Ampio Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $26,716 - $78,480	166,979 Added 73.52%	394,100 $66,000
Q1 2022 May 16, 2022	BUY	$0.42 - $0.62 $21,504 - $31,744	51,200 Added 29.1%	227,121 $107,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $26,040 - $79,515	46,500 Added 35.93%	175,921 $100,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $802 - $1,193	663 Added 0.51%	129,421 $215,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $24,270 - $30,804	15,558 Added 13.74%	128,758 $215,000
Q1 2021 May 17, 2021	SELL	$1.36 - $2.49 $61,200 - $112,050	-45,000 Reduced 28.45%	113,200 $191,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $118,650 - $436,631	158,200 New	158,200 $252,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.